HERAMED Limited (HMD) is focused on the commercialization and deployment of their innovative HeraCARE pregnancy monitoring solution. This patient-centered technology empowers expecting mothers and healthcare providers with valuable insights throughout the pregnancy journey. HMD has generated revenue related to the provision of these vital monitoring services under key contracts with customers. This revenue stream is driven by the delivery of their user-friendly HeraCARE software platform and the state-of-the-art HeraBEAT monitoring devices, which work in tandem to provide a comprehensive picture of maternal and fetal health.